НОВАЯ СТАТЬЯ
Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem-Cell Transplantation in the Letermovir Era.
The length of hospital stays after HSCT was observed to be shorter following the introduction of letermovir in this study. This reduction in hospital stays did not decrease hospitalization costs in relation to allogeneic HSCT, but it may alleviate the burden on both patients and healthcare providers.